The BOT study results are super interesting for IHL.
the BOT study only had 10-15 patients but IHL is doing up to 40 per clinical trial per the presso. Also they called theirs a study but ours are trials so I wonder if there is a difference there?
at 15 cents BOT has a market capitalisation of about 115M. a few others mentioned it was about 100 only a week or so ago.
great to see that clinical trials are the new game in town for pot stocks
glta
IHL Price at posting:
3.3¢ Sentiment: Buy Disclosure: Held
